$OCGN Pfizer Inc. said its Covid-19 vaccine was granted priority review by U.S. regulators, putting it on track for a potential full approval by early next year. ... According to data from the Centers for Disease Control and Prevention, some 85 million people have been fully vaccinated with the two-dose regimen
1 Like